Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymphoma']
glofitamab (cd20/cd3) in r/r lbcl, focused on pts who achieve cr after eot by durable responses after 1st cr. more follow-up needed! #lymphoma #ash22 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes